Concepedia

Alfred Sandrock

AS

43

Publications

15.5K

Citations

31

H-Index

1980

Active since

Affiliations

Biogen (United States)(Current)

Harvard University

University College London

University Hospital of Basel

Butler Hospital

Alfred Sandrock is an author at Biogen (United States) specializing in medicine, neuroimmunology, and immunology.

Top concepts

Publications per year

1980–2024

43

Publications

43

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3K citations

, , +7

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis

Lawrence Jacobs, Roy W. Beck, Jack H. Simon et al. · New England Journal of Medicine · 2000 · 1.5K citations · Full text

, , +12

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease

Samantha Budd Haeberlein, Paul Aisen, Frederik Barkhof et al. · The Journal of Prevention of Alzheimer s Disease · 2022 · 1.2K citations · Full text

Rows per page

1–5 of 43